Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents
P. Franchetti, and M. Grifantini Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents Curr. Med. Chem. 6 1999 599 614 (Pubitemid 29328003)
Computer-assisted structure-activity correlations of dideoxynucleoside analogs as potential anti-HIV drugs
DOI 10.1016/0166-3542(90)90030-B
M. Nasr, C. Litterst, and J. McGowan Computer-assisted structure-activity correlations of dideoxynucleoside analogs as potential anti-HIV drugs Antivir. Res. 14 1990 125 148 (Pubitemid 20300731)
Synthesis and anti-hepatitis B virus activity of 9-(2-Deoxy-2-fluoro- β-L-arabinofuranosyl)purine nuleosides
DOI 10.1021/jm970233+
T. Ma, J.S. Lin, M.G. Newton, Y.-C. Cheng, and C.K. Chu Synthesis and anti-hepatitis B virus activity of 9-(2-Deoxy-2-fluoro-β-l-arabino furanosyl)purine Nucleosides J. Med. Chem. 40 1997 2750 2754 (Pubitemid 27366455)
Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults
R.R. Ellison, J.F. Holland, M. Weil, C. Jacquillat, M. Boiron, J. Bernard, A. Sawitsky, F. Rosner, B. Gussoff, R.T. Silver, A. Karanas, J. Cuttner, C.L. Spurr, D.M. Hayes, J. Blom, L.A. Leone, F. Haurani, R. Kyle, J.L. Hutchison, R.J. Forcier, and J.H. Moon Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults Blood 32 1968 507 523
The effect of 2'-fluoro-2'-deoxycytidine on herpes virus growth
DOI 10.1016/0167-4781(85)90053-3
F. Wohlrab, A.T. Jamieson, J. Hay, R. Mengel, and W. Guschlbauer The effect of 2′-fluoro-2′-deoxycytidine on herpes virus growth Biochim. Biophys. Acta 824 1985 233 242 (Pubitemid 15114442)
2′-Fluoro-2′-Deoxycytidine Inhibits Borna Disease Virus Replication and Spread
DOI 10.1128/AAC.48.4.1422-1425.2004
J.J. Bajramovic, R. Volmer, S. Syan, S. Pochet, and D.G. Dunia 2′-fluoro-2′-deoxycytidine inhibits Borna disease virus replication and spread Antimicrob. Agents Chemother. 48 2004 1422 1425 (Pubitemid 38405511)
Inhibition of the Subgenomic Hepatitis C Virus Replicon in Huh-7 Cells by 2′-Deoxy-2′-Fluorocytidine
DOI 10.1128/AAC.48.2.651-654.2004
L.J. Stuyver, T.R. McBrayer, T. Whitaker, P.M. Tharnish, M. Ramesh, S. Lostia, L. Cartee, J. Shi, A. Hobbs, R.F. Schinazi, K.A. Watanabe, and M.J. Otto Inhibition of the subgenomic hepatitis C virus replicon in Huh-7 cells by 2′-deoxy-2′-fluorocytidine Antimicrob. Agents Chemother. 48 2004 651 654 (Pubitemid 38141737)
Nucleosides. CX. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides
K.A. Watanabe, U. Reichman, K. Hirota, C. Lopez, and J.J. Fox Nucleosides. 110. Synthesis and antiherpes virus activity of some 2′-fluoro-2′-deoxyarabinofuranosylpyrimidine nucleosides J. Med. Chem. 22 1979 21 24 (Pubitemid 9082471)
Inhibition of influenza A and B viruses by 29-deoxy-29-fluororibosides
M. Tisdale, G. Appleyard, J.V. Tuttle, D.J. Nelson, S. Nusinoff-Lehrman, W.A. Nakib, J.N. Stables, D.J.M. Purifoy, K.L. Powell, and G. Darby Inhibition of influenza A and B viruses by 29-deoxy-29-fluororibosides Antivir. Chem. Chemother. 4 1993 281 287
In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections
Y. Kumaki, C.W. Day, D.F. Smee, J.D. Morrey, and D.L. Barnard In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections Antivir. Res. 92 2011 329 340
2' Deoxy 2' azidocytidine, a new inhibitor of DNA replication in mammalian cells
DOI 10.1111/j.1432-1033.1977.tb11261.x
L. Skoog, G. Bjursell, L. Thelander, T. Hagerstrom, J. Hobbs, and F. Eckstein 2′-Deoxy-2′-azidocytidine, a new inhibitor of DNA replication in mammalian cells Eur. J. Biochem 72 1977 371 378 (Pubitemid 8022236)
2′-Deoxy-2′-azidocytidine inhibits the initiation of polyoma DNA synthesis
V. Bianchi, S. Borella, F. Calderazzo, P. Ferraro, L.C. Bianchi, and P. Reichard 2′-Deoxy-2′-azidocytidine inhibits the initiation of polyoma DNA synthesis Proc. Natl. Acad. Sci. U. S. A 91 1994 8403 8407
Antiviral, antimetabolic and antineoplastic activities of 2'- or 3'-amino or -azido-substituted deoxyribonucleosides
DOI 10.1016/0006-2952(80)90149-5
E. De Clercq, J. Balzarini, J. Descamps, and F. Eckstein Antiviral, antimetabolic and antineoplastic activities of 2′-or 3′-amino or -azido-substituted deoxyribonucleosides Biochem. Pharmacol. 29 1980 1849 1851 (Pubitemid 10071393)
Azidocytidine is a specific inhibitor of deoxyribonucleotide synthesis in 3T6 cells
L. Akerblom, and P. Reichard Azidocytidine is a specific inhibitor of deoxyribonucleotide synthesis in 3T6 cells J. Biol. Chem. 260 1985 9197 9202 (Pubitemid 15249899)
Synthesis and biological activity of phosphonated nucleosides: Part 1. Furanose, carbocyclic and heterocyclic analogues
DOI 10.2174/092986706779026110
A. Piperno, M.A. Chiacchio, D. Iannazzo, and R. Romeo Synthesis and biological activity of phosphonated nucleosides: part 1 furanose, carbocyclic and heterocyclic analogues Curr. Med. Chem. 13 2006 3675 3695 (Pubitemid 44873738)
Biocatalytic selective modifications of conventional nucleosides, carbocyclic nucleosides, and C-nucleosides
M. Ferrero, and V. Gotor Biocatalytic selective modifications of conventional nucleosides, carbocyclic nucleosides, and C-nucleosides Chem. Rev. 100 2000 4319 4348
Recent advances in the synthesis of the carbocyclic nucleosides as potential antiviral agents
J.A. Lee, and L.S. Jeong Recent advances in the synthesis of the carbocyclic nucleosides as potential antiviral agents Antivir. Chem. Chemother. 15 2004 235 250 (Pubitemid 39452242)
Synthesis and antiviral evaluation of carbocyclic analogs of 2′-azido- and 2′-amino-2′-deoxycytidine
T.-S. Lin, X.-H. Zhang, Z.-H. Wang, and W.H. Prusoff Synthesis and antiviral evaluation of carbocyclic analogs of 2′-azido- and 2′-amino-2′-deoxycytidine J. Med. Chem. 31 1988 484 486
Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine
DOI 10.1016/S0304-3835(98)00089-5, PII S0304383598000895
S. Miura, Y. Yoshimura, M. Endo, H. Machida, A. Matsuda, M. Tanaka, and T. Sasaki Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-β-d-arabinofuranosyl)cytosine Cancer Lett. 129 1998 103 110 (Pubitemid 28375244)
Anti-herpesvirus activity profile of 4'-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-β-D-2'-fluoro-4'-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus
DOI 10.1016/S0166-3542(98)00042-4, PII S0166354298000424
H. Machida, N. Ashida, S. Miura, M. Endo, K. Yamada, K. Kitano, Y. Yoshimura, S. Sakata, O. Ijichi, and Y. Eizuru Anti-herpesvirus activity profile of 4′-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-β-d-2′-fluoro-4′-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus Antivir. Res. 39 1998 129 137 (Pubitemid 29027863)
A novel synthesis of 2′-Modified 2′-Deoxy-4′- thiocytidines from d-glucose
Y. Yoshimura, K. Kitano, K. Yamada, H. Satoh, M. Watanabe, S. Miura, S. Sakata, T. Sasaki, and A. Matsuda A novel synthesis of 2′-Modified 2′-Deoxy-4′-thiocytidines from d-glucose J. Org. Chem. 62 1997 3140 3152
First synthesis of 4′-selenonucleosides showing unusual Southern conformation
L.S. Jeong, D.K. Tosh, H.O. Kim, T. Wang, X. Hou, H.S. Yun, Y. Kwon, S.K. Lee, J. Choi, and L.X. Zhao First synthesis of 4′-selenonucleosides showing unusual Southern conformation Org. Lett. 10 2008 209 212
Stereoselective synthesis and conformational study of novel 2′,3′-didehydro-2′,3′-dideoxy-4′-selenonucleosides
DOI 10.1021/jo8003277
D.K. Tosh, W.J. Choi, H.O. Kim, Y. Lee, S. Pal, X. Hou, J. Choi, S. Choi, and L.S. Jeong Stereoselective synthesis and conformational study of novel 2′,3′-didehydro-2′,3′-dideoxy-4′- selenonucleosides J. Org. Chem. 73 2008 4259 4262 (Pubitemid 351812936)
Discovery of a new template for anticancer agents: 2′-deoxy- 2′-fluoro-4′-selenoarabinofuranosyl-cytosine (2′-F-4′- seleno-ara-C)
L.S. Jeong, D.K. Tosh, W.J. Choi, S.K. Lee, Y.-J. Kang, S. Choi, J.H. Lee, H.K. Lee, H.W. Lee, and H.O. Kim Discovery of a new template for anticancer agents: 2′-deoxy-2′-fluoro-4′-selenoarabinofuranosyl-cytosine (2′-F-4′-seleno-ara-C) J. Med. Chem. 52 2009 5303 5306
A new DNA building block, 4′-selenothymidine: Synthesis and modification to 4′-seleno-AZT as a potential anti-HIV agent
V. Alexander, W.J. Choi, J. Chun, H.O. Kim, J.H. Jeon, D.K. Tosh, H.W. Lee, G. Chandra, J. Choi, and L.S. Jeong A new DNA building block, 4′-selenothymidine: synthesis and modification to 4′-seleno-AZT as a potential anti-HIV agent Org. Lett. 12 2010 2242 2245
New RNA purine building blocks, 4′-selenopurine nucleosides: First synthesis and unusual mixture of sugar puckerings
J. Yu, J.-H. Kim, H.W. Lee, V. Alexander, H.-C. Ahn, W.J. Choi, J. Choi, and L.S. Jeong New RNA purine building blocks, 4′-selenopurine nucleosides: first synthesis and unusual mixture of sugar puckerings Chem. Eur. J. 19 2013 5528 5532
A new DNA building block, 4′-selenothymidine: Synthesis and modification to 4′-seleno-AZT as a potential anti-HIV agent
K. Jayakanthan, B.D. Johnston, and B.M. Pinto A new DNA building block, 4′-selenothymidine: synthesis and modification to 4′-seleno-AZT as a potential anti-HIV agent Carbohydr. Res. 343 2008 1790 1800
A concise, efficient and production-scale synthesis of a protected L-lyxonolactone derivative: An important aldonolactone core
DOI 10.1021/op050222n
H. Batra, R.M. Moriarty, R. Penmasta, V. Sharma, G. Stanciuc, J.P. Staszewski, S.M. Tuladhar, and D.A. Walsh A concise, efficient and production-scale synthesis of a protected l-lyxonolactone derivative: an important aldonolactone core Org. Process Res. Dev. 10 2006 484 486 (Pubitemid 44012687)
Induction of apoptosis by 1,4-phenylenebis(methylene)selenocyanate in cultured human colon cancer cells
A
S.K. Lee, Y.H. Heo, V.E. Steelee, and J.M. Pezzuto Induction of apoptosis by 1,4-phenylenebis(methylene)selenocyanate in cultured human colon cancer cells Anticancer Res. 22 2002 97 102 (Pubitemid 34475281)
Cellular pharmacology and optimal therapeutic concentrations of 1-β-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-β-D- arabinofuranosylcytosine
W. Plunkett, S. Iacoboni, and M.J. Keating Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5′-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosine Scand. J. Haematol. Suppl. 44 1986 51 59 (Pubitemid 16155999)
